Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse

National Institutes of Health (NIH)

Status and phase

Completed

Phase 1

Conditions

Cocaine Abuse

Opioid Dependence

Treatments

Behavioral: Contingency Management

Drug: Methadone

Study type

Interventional

Funder types

NIH

Identifiers

NCT00292123

NIDAIRP 326

Details and patient eligibility

About

The primary goal of this study is to determine how contingency management can best be combined with standard or high doses of methadone to increase simultaneous abstinence from heroin and cocaine.

Full description

A study of people pmaintained on Methadone using contingency management

Enrollment

200 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Opioid dependence; cocaine use

Exclusion criteria

Medical or psychiatric conditions that would contraindicate participation in a methadone maintenance study; inability to give informed consent; inability to attend clinic seven days a week